Nuvalent joins the IPO party less than 6 months after launch, while Icosavax kicks its 'soccer ball' VLPs to Nasdaq

Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent is already prepping a jump to Nasdaq. And it’s a leap that could prove highly profitable for the blue chip firm.